Highbridge Capital Management’s Vigil Neuroscience VIGL Stock Holding History

Highbridge Capital Management’s Portfolio VIGL Stock Details VIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-865,036	Closed	-$6.88M	–	332
2025 Q2	$6.88M	Buy	+865,036	New	+$3.88M	0.28%	69

Other funds holding VIGL

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Highbridge Capital Management's VIGL Position: Q3 2025 in Review

Highbridge Capital Management sold out of Vigil Neuroscience (VIGL) in Q3 2025, closing a stake of 865,036 shares — an estimated $6.88M sold.

Highbridge Capital Management first reported a position in VIGL in Q2 2025 and held it in 1 quarter. The position peaked at $6.88M in Q2 2025. 2 funds tracked by Wall St. Rank hold VIGL as of Q3 2025.

Highbridge Capital Management reported no remaining Vigil Neuroscience position as of Q3 2025 after selling out during the quarter.
Highbridge Capital Management sold 865,036 Vigil Neuroscience shares in Q3 2025, an estimated $6.88M.
Highbridge Capital Management first reported a position in Vigil Neuroscience in Q2 2025 and held it in 1 quarter.
Highbridge Capital Management's Vigil Neuroscience position peaked at $6.88M in Q2 2025.
2 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2025.

Based on Highbridge Capital Management's 13F filing for Q3 2025, filed 10 Nov 2025.